Hormonal health in 2026 has expanded to address Polycystic Ovary Syndrome (PCOS) and its long-term metabolic consequences.

• Metabolic Synchronization: Treatment protocols now integrate hormone therapy with metabolic modulators (like GLP-1 agonists or Metformin) to address insulin resistance and androgen dominance.

• Phenotypic Variations: Clinicians now use "Phenotypic Diagnostics" to distinguish between different presentations of PCOS, ensuring that the hormonal intervention—whether for fertility or metabolic health—is precisely targeted.

• Lifestyle Integration: 2026 care models emphasize a "collective approach," where hormonal restoration is supported by specialized nutrition, stress-reduction adaptogens, and resistance training to preserve muscle mass (sarcopenia prevention).